Literature DB >> 16206348

Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.

José Alvarez-Nemegyei1, Julio Cesar Cen-Pisté, Martha Medina-Escobedo, Salha Villanueva-Jorge.   

Abstract

OBJECTIVE: . To assess the association between a set of sociodemographic, clinical, and biochemical variables and the presence of musculoskeletal (MSK) disability and chronic renal failure in patients with primary gout defined using Wallace criteria.
METHODS: Subjects were 90 patients with primary gout (98% male, age 54 +/- 12 years, 11.3 +/- 9.8 years with gout). A cohort nested case-control design was used. Analysis was done of the association between MSK disability or renal failure and a series of variables: age; duration of gout; body mass index; education level; income; serum glucose, cholesterol, triglycerides, and uric acid; Health Assessment Questionnaire score; obesity; family history of gout; high blood pressure; alcoholism; smoking habit; presence of tophi; ischemic cardiopathy; and use of colchicine, glucocorticoids, nonsteroidal antiinflammatory drug, or allopurinol.
RESULTS: Forty-two patients (47%) had MSK disability, and 25/80 (31%) had renal failure. On logistic regression, presence of tophi (relative risk 4.3, 95% confidence interval 1.2-15.1), hypertriglyceridemia (RR 3.4, 95% CI 1.1-10), and history of ischemic heart disease (RR 8.3, 95% CI 1.6-41) were associated with MSK disability. Patient age was the only variable associated with renal failure.
CONCLUSION: Optimal medical control of gout and its comorbidities may improve prognosis of gout, as suggested by our findings, in which a marker for poorly controlled gout such as presence of tophi in addition to high blood triglyceride levels and ischemic heart disease were associated with MSK disability. Older age was the only factor associated with renal failure, although this may only reflect declining renal function in the elderly.

Entities:  

Mesh:

Year:  2005        PMID: 16206348

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

Review 2.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

3.  Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?

Authors:  Lisa K Stamp; Puja P Khanna; Nicola Dalbeth; Maarten Boers; Walter P Maksymowych; H Ralph Schumacher; Michael A Becker; Patricia A MacDonald; N Lawrence Edwards; Jasvinder A Singh; Lee S Simon; Fiona M McQueen; Tuhina Neogi; Angelo L Gaffo; Vibeke Strand; William J Taylor
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

4.  Predictors of activity limitation in people with gout: a prospective study.

Authors:  Sarah Stewart; Keith Rome; Alastair Eason; Meaghan E House; Anne Horne; Anthony J Doyle; Julie Knight; William J Taylor; Nicola Dalbeth
Journal:  Clin Rheumatol       Date:  2018-04-21       Impact factor: 2.980

5.  Chronic kidney disease in gout in a managed care setting.

Authors:  Mahesh J Fuldeore; Aylin A Riedel; Victoria Zarotsky; Bhavik J Pandya; Omar Dabbous; Eswar Krishnan
Journal:  BMC Nephrol       Date:  2011-08-03       Impact factor: 2.388

6.  Gout disease-specific quality of life and the association with gout characteristics.

Authors:  Jan D Hirsch; Robert Terkeltaub; Dinesh Khanna; Jasvinder Singh; Andrew Sarkin; Micki Shieh; Arthur Kavanaugh; Susan J Lee
Journal:  Patient Relat Outcome Meas       Date:  2010-03-01

7.  Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR).

Authors:  Carlo A Scire; Maria Manara; Marco A Cimmino; Marcello Govoni; Fausto Salaffi; Leonardo Punzi; Maria C Monti; Greta Carrara; Carlomaurizio Montecucco; Marco Matucci-Cerinic; Giovanni Minisola
Journal:  Arthritis Res Ther       Date:  2013-08-23       Impact factor: 5.156

Review 8.  Health-related quality of life in gout: a systematic review.

Authors:  Priyanka Chandratre; Edward Roddy; Lorna Clarson; Jane Richardson; Samantha L Hider; Christian D Mallen
Journal:  Rheumatology (Oxford)       Date:  2013-08-11       Impact factor: 7.580

9.  "You want to get on with the rest of your life": a qualitative study of health-related quality of life in gout.

Authors:  Priyanka Chandratre; Christian D Mallen; Edward Roddy; Jennifer Liddle; Jane Richardson
Journal:  Clin Rheumatol       Date:  2015-08-06       Impact factor: 2.980

10.  Health-related quality of life in gout in primary care: Baseline findings from a cohort study.

Authors:  Priyanka Chandratre; Christian Mallen; Jane Richardson; Sara Muller; Samantha Hider; Keith Rome; Milisa Blagojevic-Bucknall; Edward Roddy
Journal:  Semin Arthritis Rheum       Date:  2018-01-05       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.